Minimally invasive glaucoma surgery - current and emerging techniques to reduce intraocular pressure and medications

Abstract

Minimally invasive glaucoma surgery (MIGS) has become increasingly popular as a step in the management pathway of open angle glaucoma. Due to the relative novelty of these devices, there remains some paucity of evidence relating to their long-term efficacy and safety, and this can make comparison between these techniques somewhat complex. This review article aims to guide clinical decision making by providing the latest evidence on the comparative efficacy of current iterations of minimally invasive glaucoma surgery. A literature review was conducted to identify the most significant recent evidence to support the safety and efficacy of the various forms of minimally invasive glaucoma surgery. Included studies provided efficacy and safety data on a variety of minimally invasive glaucoma surgery methods. The PubMed database was searched and a total of 484 studies, published between 2015 and 2020 were identified, of which 27 were included. The studies indicate that most available forms of minimally invasive glaucoma surgery show statistically significant efficacy in terms of intra-ocular pressure reduction and improvement in medication burden, while maintaining an acceptable safety profile.

Keywords

Minimally invasive glaucoma surgery / open angle glaucoma / trabecular microbypass / ab-interno canaloplasty / trabeculectomy / suprachoroidal / subconjunctival

References

[1] Weinreb RN,Medeiros FA.The Pathophysiology and Treatment of Glaucoma..JAMA2014;311:1901-11 PMCID:PMC4523637

[2] McClelland JF,Little JA.Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes..Patient Prefer Adherence2019;13:431-9 PMCID:PMC6697779

[3] Eldaly MA,Elsheikha OZ.Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma..Cochrane Database Syst Rev2014;CD007059

[4] Samuelson TW,Marquis R.A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: The HORIZON study..Ophthalmology2019;126:29-37

[5] Hooshmand J,Allen P,Vote BJ.Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma..Clin Exp Ophthalmol2019;47:898-903

[6] Ferguson TJ,Schweitzer J,Stephens JD.Trabecular micro-bypass stent implantation with cataract extraction in pigmentary glaucoma..Clin Exp Ophthalmol2020;48:37-43

[7] Ferguson TJ,Ibach M,Sudhagoni R.Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma..J Cataract Refract Surg2017;43:622-6

[8] Ahmed IIK,Au L.A prospective randomized trial comparing hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: The COMPARE study..Ophthalmology2020;127:52-61

[9] Katz LJ,Carceller Guillamet A.Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes..Clin Ophthalmol2018;12:255-62 PMCID:PMC5798569

[10] Samuelson TW,Lubeck DM.Prospective, randomized, controlled pivotal trial of an Ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results..Ophthalmology2019;12:811-21

[11] Davids AM,Boeker A,Maier-Wenzel AK.Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS)..Graefes Arch Clin Exp Ophthalmol2019;257:1947-53

[12] Heersink M.Ab interno canaloplasty combined with trabecular bypass stenting in eyes with primary open-angle glaucoma..Clin Ophthalmol2019;13:1533-42 PMCID:PMC6697664

[13] Esfandiari H,Shah P.Two-year data comparison of ab interno trabeculectomy and trabecular bypass stenting using exact matching..J Cataract Refract Surg2019;45:608-14

[14] Avar M,Neuburger M.Long-term follow-up of intraocular pressure and pressure-lowering medication in patients after ab-interno trabeculectomy with the Trabectome..Graefes Arch Clin Exp Ophthalmol.2019;257:997-1003

[15] Olgun A,Ucgul AY.XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma..Int Ophthalmol2020;40:1085-93

[16] ElMallah MK,Kahook MY.12-month retrospective comparison of Kahook dual blade excisional goniotomy with istent trabecular bypass device implantation in glaucomatous eyes at the time of cataract surgery..Adv Ther2019;36:2515-27 PMCID:PMC6822852

[17] Vold S,Craven ER.Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts..Ophthalmology2016;123:2103-12

[18] Reiss G,Vold S.Safety and effectiveness of cypass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study..Am J Ophthalmol2019;208:219-25

[19] Mahdavi Fard A,Pourafkari L.Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis..Ther Adv Chronic Dis2019;10:2040622318820850 PMCID:PMC6357298

[20] Myers JS,Hornbeak DM.Prospective evaluation of two iStent((R)) trabecular stents, one iStent Supra((R)) suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes..Adv Ther2018;35:395-407 PMCID:PMC5859115

[21] Pantalon AD,Georgopoulos M.Outcomes of phacoemulsification combined with two iStent inject trabecular microbypass stents with or without endocyclophotocoagulation..Br J Ophthalmol.2020;104:1378-83

[22] Karimi A,Turnbull A.A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery..Eye (Lond).2019;33:469-77 PMCID:PMC6460711

[23] Wagner FM,Emmerich J,Hoffmann EM.Efficacy and safety of XEN(R)-Implantation vs. trabeculectomy: Data of a “real-world” setting..PLoS One2020;15:e0231614 PMCID:PMC7170231

[24] Gillmann K,Mermoud A,Mansouri K.XEN gel stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation..J Glaucoma2019;28:676-84

[25] Sadruddin O,Angeles R.Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review..Eye Vis (Lond).2019;6:36 PMCID:PMC6857290

[26] Pillunat LE,Junemann AG.Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents..Clin Ophthalmol.2017;11:1583-600 PMCID:PMC5587165

[27] Kerr N. MIGS: what’s happening now and on the Horizon. Glaucoma Australia 2019. Available from: https://glaucoma.org.au/news-details/treatment/migs-whats-happening-now-and-on-the-horizon. [Last Accessed on 1 Mar 2021].

[28] Toth M,Hu K,Gazzard G.Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure..Cochrane Database Syst Rev2019;2:CD012741 PMCID:PMC6388466

[29] Shah M.Micro-invasive glaucoma surgery - an interventional glaucoma revolution..Eye Vis (Lond).2019;6:29 PMCID:PMC6766174